Biotechnology company MDRNA Inc. said Tuesday it bought DNA technology-related patents from Valeant Pharmaceuticals for an undisclosed amount.
128654
MDRNA buys DNA technology from Valeant Pharmaceuticals for undisclosed amount
79889
Merck buys drug rival Schering-Plough
112374
AdnaGen enters into agreement to license antibodies to KellBenx
143854
MedAssets completes acquisition of
120427
Life Technologies acquires BAC BV
72886
Gilead Sciences completes acquisition of YM BioSciences
4381
Facebook buys AOL patents from Microsoft
23554
Storediq acquired by IBM
31894
Merck to buy Schering-Plough for $41 billion
116083
Rosetta Genomics completes direct offering;
28286
DuPont successfully completes tender offer for
139672
ZymoGenetics sells parcel for $11.5 million
166022
CollabRx and OncoDNA announce multi-year agreement
53771
Millipore acquires BioAnaLab
93576
Shire acquires biopharmaceutical company SARcode
17997
Sony Computer Entertainment acquires Media Molecule
91320
Alnylam consolidates intellectual property for RNA activation